- Therapeutic Solutions International Granted Patent on Commercially Available QuadraMune® Nutraceutical for Increasing Natural Killer Cell Immunity in COVID-19 Patients
- Therapeutic Solutions International Announces Landmark Finding Regarding Mechanism of Action of its JadiCell Stem Cell Product
- Therapeutic Solutions International Files Patent on “Facilitating Effects” of JadiCells on Gene Therapy Mediated Cell Differentiation
Key statistics
On Friday, Therapeutic Solutions International Inc (TSOI:PKC) closed at 0.0006, 20.00% above the 52 week low of 0.0005 set on Apr 25, 2024.
52-week range
Open | 0.0006 |
---|---|
High | 0.0007 |
Low | 0.0006 |
Bid | -- |
Offer | -- |
Previous close | 0.0006 |
Average volume | 24.98m |
---|---|
Shares outstanding | 4.23bn |
Free float | 3.42bn |
P/E (TTM) | -- |
Market cap | 2.54m USD |
EPS (TTM) | -0.0007 USD |
Data delayed at least 15 minutes, as of Apr 26 2024 21:00 BST.
More ▼